Common Contracts
6 similar Warrant Exchange Agreement contracts by SELLAS Life Sciences Group, Inc.
SELLAS LIFE SCIENCES GROUP, INC. WARRANT EXCHANGE AGREEMENTWarrant Exchange Agreement • April 13th, 2018 • SELLAS Life Sciences Group, Inc. • Pharmaceutical preparations • New York
This Warrant Exchange Agreement (this “Agreement”) is made as of February 9, 2018 (“Effective Date”), by and between SELLAS Life Sciences Group, Inc., a Delaware corporation (the “Company”), and HUDSON BAY MASTER FUND LTD ( collectively, the “Holder”).
SELLAS LIFE SCIENCES GROUP, INC. WARRANT EXCHANGE AGREEMENTWarrant Exchange Agreement • April 13th, 2018 • SELLAS Life Sciences Group, Inc. • Pharmaceutical preparations • New York
This Warrant Exchange Agreement (this “Agreement”) is made as of February 21, 2018 (“Effective Date”), by and between SELLAS Life Sciences Group, Inc., a Delaware corporation (the “Company”), and EMPERY ASSET MASTER, LTD. ( collectively, the “Holder”).
SELLAS LIFE SCIENCES GROUP, INC. WARRANT EXCHANGE AGREEMENTWarrant Exchange Agreement • April 13th, 2018 • SELLAS Life Sciences Group, Inc. • Pharmaceutical preparations • New York
This Warrant Exchange Agreement (this “Agreement”) is made as of February 21, 2018 (“Effective Date”), by and between SELLAS Life Sciences Group, Inc., a Delaware corporation (the “Company”), and EMPERY TAX EFFICIENT, LP ( collectively, the “Holder”).
SELLAS LIFE SCIENCES GROUP, INC. WARRANT EXCHANGE AGREEMENTWarrant Exchange Agreement • April 13th, 2018 • SELLAS Life Sciences Group, Inc. • Pharmaceutical preparations • New York
This Warrant Exchange Agreement (this “Agreement”) is made as of February 21, 2018 (“Effective Date”), by and between SELLAS Life Sciences Group, Inc., a Delaware corporation (the “Company”), and EMPERY TAX EFFICIENT II, LP ( collectively, the “Holder”).
SELLAS LIFE SCIENCES GROUP, INC. WARRANT EXCHANGE AGREEMENTWarrant Exchange Agreement • April 13th, 2018 • SELLAS Life Sciences Group, Inc. • Pharmaceutical preparations • New York
This Warrant Exchange Agreement (this “Agreement”) is made as of February 6, 2018 (the ”Effective Date”), by and between SELLAS Life Sciences Group, Inc., a Delaware corporation (the “Company”), and CVI INVESTMENTS, INC. (the “Holder”). This Agreement hereby supersedes and replaces that certain Warrant Exchange Agreement entered into by the Company and Holder effective as of the Effective Date (the “Original Agreement”), and the Original Agreement shall have no further force or effect from and after the execution of this Agreement.
SELLAS LIFE SCIENCES GROUP, INC. WARRANT EXCHANGE AGREEMENTWarrant Exchange Agreement • April 13th, 2018 • SELLAS Life Sciences Group, Inc. • Pharmaceutical preparations • New York
This Warrant Exchange Agreement (this “Agreement”) is made as of February 13, 2018 (the “Effective Date”), by and between SELLAS Life Sciences Group, Inc., a Delaware corporation (the “Company”), and Alto Opportunity Master Fund, SPC—Segregated Master Portfolio B (the “Holder”). This Agreement hereby supersedes and replaces that certain Warrant Exchange Agreement entered into by the Company and Holder effective as of the Effective Date (the “Original Agreement”), and the Original Agreement shall have no further force or effect from and after the execution of this Agreement.
